Cardio Diagnostics Holdings Inc (CDIO)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $5.30M
Last updated: Nov 17, 2026 at 4:10 PM ET
Cardio Diagnostics Holdings Inc (CDIO) Statistics
Cardio Diagnostics Holdings (CDIO) has a market cap of $5.30M and an enterprise value of $1.35M. It kept -42721.93% of revenue as net income over the last 12 months. Its share count is up 68.35% from a year earlier.
Total Valuation
Enterprise value is 74.43% below the market cap, as cash exceeds debt.
| Market Cap | $5.30M |
|---|---|
| Enterprise Value | $1.35M |
| Latest price (Nov 17, 2026) | $1.71 |
Key Dates
The next earnings report is expected on Mar 11, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 11, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 6, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 333.3x and 0.9x.
| P/S Ratio | 333.3x |
|---|---|
| P/B Ratio | 0.9x |
| P/TBV Ratio | 1.1x |
Price Statistics
The stock is down 49.85% over 52 weeks and trades 7.07% below its 50-day average.
| Beta (1Y) | 2.46 |
|---|---|
| 52-Week Change | -49.85% |
| 1-Month Change | +4.27% |
| 3-Month Change | -14.07% |
| 6-Month Change | +24.82% |
| Total Return (1Y) | -49.85% |
| Total Return (3Y CAGR) | -61.38% |
| Return vs SPY (1Y) | -48.92% |
| Max Drawdown (1Y) | -79.08% |
| Max Drawdown (3Y) | -98.86% |
| Sharpe Ratio (1Y) | -0.35 |
| Correlation with SPY (1Y) | 0.25 |
| 50-Day Average | $1.84 |
| 200-Day Average | $2.07 |
| 52-Week Range | $0.97 to $7.91 |
| RSI (14 Days) | 45.3 |
| Average Volume (20 Days) | 17.42K |
Financial Position
Current assets cover 17.44x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 17.44x |
|---|---|
| Quick Ratio | 17.44x |
| Debt / Equity | 0.00x |
| Interest Coverage | -565.89x |
Returns and Efficiency
Return on equity is -113.45% and return on assets is -106.62% over the last 12 months.
| Return on Equity (ROE) | -113.45% |
|---|---|
| Return on Assets (ROA) | -106.62% |
| Return on Capital Employed (ROCE) | -111.19% |
| ROA (5Y Average) | -96.25% |
| ROIC (5Y Average) | -63.54% |
| Asset Turnover | 0.00x |
| Receivables Turnover | 4.07x |
Scores
CDIO has an Altman Z-Score of -2.30, in the distress zone below 1.81, and a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -2.30 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 1 of 9 |
| Piotroski Strength | Weak |
Income Statement
Revenue of $15.19K over the last 12 months is down 3.78% from the 12 months before.
| Revenue | $15.19K |
|---|---|
| Revenue Growth (YoY) | -3.78% |
| Gross Profit | $15.19K |
| Operating Income | -$6.48M |
| Pretax Income | -$6.49M |
| Net Income | -$6.49M |
| EBITDA | -$6.11M |
| EBIT | -$6.49M |
| Reported EPS (TTM) | -$2.53 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 94.08% of the $6.08M in total assets.
| Cash and Equivalents | $3.94M |
|---|---|
| Total Debt | $0 |
| Net Cash | $3.94M |
| Net Cash Per Share | $1.33 |
| Working Capital | $4.10M |
| Shareholder Equity | $5.72M |
| Book Value Per Share | $1.93 |
| Tangible Book Value | $4.69M |
| Tangible Book Per Share | $1.59 |
| Total Assets | $6.08M |
| Total Liabilities | $366.00K |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | -$5.78M |
|---|---|
| FCF Per Share | -$1.96 |
| Depreciation and Amortization | $380.69K |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -42649.75%.
| Gross Margin | 100.00% |
|---|---|
| Operating Margin | -42649.75% |
| Pretax Margin | -42721.93% |
| Net Margin | -42721.93% |
| EBITDA Margin | -40214.89% |
| EBIT Margin | -42721.93% |
Growth
Revenue grew 149.89% a year over 3 years.
| Revenue Growth (3Y CAGR) | +149.89% |
|---|---|
| Book Value Per Share Growth (2Y CAGR) | +414.94% |
| Tangible Book Per Share Growth (2Y CAGR) | +432.34% |
Dividends and Yields
CDIO does not pay a dividend.
| Buyback Yield | -78.18% |
|---|---|
| Shareholder Yield | -78.18% |
Stock Splits
The last split was a 1-for-30 reverse split on May 13, 2025.
| Last Split Date | May 13, 2025 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:30 |
Peer Position
Against 5 similar companies, CDIO has the highest P/S.
P/S RatioPeer median 13.8x
Revenue Growth (Trailing 4 Quarters, YoY)Peer median -98.74%
| P/S Ratio | 333.3x vs 13.8x median |
|---|---|
| Revenue Growth (Trailing 4 Quarters, YoY) | -3.78% vs -98.74% median |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About CDIO
What is CDIO's market cap?
Cardio Diagnostics Holdings has a market cap of $5.30M. Its enterprise value, which adds debt and subtracts cash, is $1.35M.
How many shares of CDIO are outstanding?
Cardio Diagnostics Holdings has 2.96M shares outstanding. The count is up 68.35% from a year earlier.
Does CDIO pay a dividend?
No. Cardio Diagnostics Holdings does not pay a dividend.
How much debt does CDIO have?
Cardio Diagnostics Holdings has $0 of total debt and $3.94M of cash and equivalents, a net cash position of $3.94M.
CDIO pages: Overview, Charting, Earnings, Financials, Statistics, Competitors